Single User License
INR 168725
Site License
INR 337450
Corporate User License
INR 506175

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Burns Global Clinical Trials Review, H1

Burns Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Burns Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Burns Global Clinical Trials Review, H1, 2015" provides an overview of Burns clinical trials scenario. This report provides top line data relating to the clinical trials on Burns. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Burns 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Burns to Dermatology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Burns to Dermatology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Burns 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Burns Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Burns 34

May 04, 2015: Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 34

Apr 29, 2015: Poster Presentation Highlighting NexoBrid Awarded Best-in-Category in Wound Care Practice at the American Burn Association 47th Annual Meeting 34

Apr 23, 2015: Cytori Reports Preclinical and Mechanistic Data Supporting Use of Cytori Cell Therapy in Wounds Combining Thermal Burn and Radiation Exposure 35

Apr 21, 2015: MediWound's NexoBrid Highlighted in Presentations at the 2015 American Burn Association 47th Annual Meeting 36

Apr 20, 2015: MediWound Initiates U.S. Phase 3 Trial With NexoBrid to Treat Severe Burns 36

Clinical Trial Profiles 38

Clinical Trial Overview of Top Companies 38

MediWound Ltd. 38

Clinical Trial Overview of MediWound Ltd. 38

Fibrocell Science, Inc. 39

Clinical Trial Overview of Fibrocell Science, Inc. 39

Sun Pharmaceutical Industries Limited 40

Clinical Trial Overview of Sun Pharmaceutical Industries Limited 40

Stemnion, Inc 41

Clinical Trial Overview of Stemnion, Inc 41

Bayer AG 42

Clinical Trial Overview of Bayer AG 42

HealOr Ltd. (Inactive) 43

Clinical Trial Overview of HealOr Ltd. (Inactive) 43

GCP-Service International Ltd. & Co. KG 44

Clinical Trial Overview of GCP-Service International Ltd. & Co. KG 44

CoDa Therapeutics, Inc. 45

Clinical Trial Overview of CoDa Therapeutics, Inc. 45

BioMarin Pharmaceutical Inc. 46

Clinical Trial Overview of BioMarin Pharmaceutical Inc. 46

Baxter International Inc. 47

Clinical Trial Overview of Baxter International Inc. 47

Clinical Trial Overview of Top Institutes / Government 48

University of Texas Medical Branch at Galveston 48

Clinical Trial Overview of University of Texas Medical Branch at Galveston 48

Massachusetts General Hospital 49

Clinical Trial Overview of Massachusetts General Hospital 49

Shiraz University of Medical Sciences 50

Clinical Trial Overview of Shiraz University of Medical Sciences 50

Shriners Hospitals for Children 51

Clinical Trial Overview of Shriners Hospitals for Children 51

Tehran University of Medical Sciences 52

Clinical Trial Overview of Tehran University of Medical Sciences 52

U.S. Army Institute of Surgical Research 53

Clinical Trial Overview of U.S. Army Institute of Surgical Research 53

Association of Dutch Burn Centres 54

Clinical Trial Overview of Association of Dutch Burn Centres 54

National Institute of General Medical Sciences 55

Clinical Trial Overview of National Institute of General Medical Sciences 55

University of Zurich 56

Clinical Trial Overview of University of Zurich 56

Changhai Hospital 57

Clinical Trial Overview of Changhai Hospital 57

Five Key Clinical Profiles 58

Appendix 80

Abbreviations 80

Definitions 80

Research Methodology 81

Secondary Research 81

About GlobalData 82

Contact Us 82

Disclaimer 82

Source 82

List of Figures

Burns Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Burns Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Burns Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Burns Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Burns Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Burns Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Burns Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Burns Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Burns to Dermatology Clinical Trials, G7 Countries (%), 2015* 15

Burns Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Burns Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Burns to Dermatology Clinical Trials, E7 Countries (%), 2015* 18

Burns Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Burns Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Burns Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Burns Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Burns Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Burns Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Burns Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Burns Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Burns Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Burns Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Burns Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 81

List of Tables

Burns Therapeutics, Global, Clinical Trials by Region, 2015* 7

Burns Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Burns Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Burns Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Burns Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Burns Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Burns Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Burns Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Burns to Dermatology Clinical Trials, G7 Countries (%), 2015* 15

Burns Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Burns Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Burns to Dermatology Clinical Trials, E7 Countries (%), 2015* 18

Burns Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Burns Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Burns Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Burns Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Burns Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Burns Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Burns Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Burns Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Burns Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Burns Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Burns Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Burns Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Burns Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by MediWound Ltd., 2015* 38

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Fibrocell Science, Inc., 2015* 39

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2015* 40

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Stemnion, Inc, 2015* 41

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 42

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by HealOr Ltd. (Inactive), 2015* 43

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by GCP-Service International Ltd. & Co. KG, 2015* 44

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by CoDa Therapeutics, Inc., 2015* 45

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2015* 46

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 47

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Medical Branch at Galveston, 2015* 48

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 49

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 50

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2015* 51

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 52

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Institute of Surgical Research, 2015* 53

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Association of Dutch Burn Centres, 2015* 54

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of General Medical Sciences, 2015* 55

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2015* 56

Burns Therapeutics Clinical Trials Market, Global, Clinical Trials by Changhai Hospital, 2015* 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

MediWound Ltd.

Fibrocell Science, Inc.

Sun Pharmaceutical Industries Limited

Stemnion, Inc

Bayer AG

GCP-Service International Ltd. & Co. KG

CoDa Therapeutics, Inc.

BioMarin Pharmaceutical Inc.

Baxter International Inc.

Burns Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Burns, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com